Home - Products - Endocrinology/Hormones - ATPase - (S)-PF-03716556

(S)-PF-03716556

CAS No. 928774-44-1

(S)-PF-03716556( —— )

Catalog No. M33699 CAS No. 928774-44-1

(S)-PF-03716556 can be used as an acid pump inhibitor for the treatment of disease conditions mediated by acid pump inhibitory activity.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	245	In Stock
10MG	363	In Stock
25MG	562	In Stock
50MG	759	In Stock
100MG	1014	In Stock
200MG	1376	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

(S)-PF-03716556
Note

Research use only, not for human use.
Brief Description

(S)-PF-03716556 can be used as an acid pump inhibitor for the treatment of disease conditions mediated by acid pump inhibitory activity.
Description

(S)-PF-03716556 can be used as an acid pump inhibitor for the treatment of disease conditions mediated by acid pump inhibitory activity.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Endocrinology/Hormones
Target

ATPase
Recptor

ATPase
Research Area

——
Indication

——

Chemical Information

CAS Number

928774-44-1
Formula Weight

394.47
Molecular Formula

C22H26N4O3
Purity

>98% (HPLC)
Solubility

——
SMILES

N(C=1C=2N(C=C(C(N(CCO)C)=O)C1)C=C(C)N2)[C@@H]3C=4C(OCC3)=CC=CC4C
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Deslanoside

Deslanoside is a rapidly acting cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms. Deslanoside inhibits the Na-K-ATPase membrane pump resulting in an increase in intracellular sodium and calcium concentrations.
NDI-091143

NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay)indirectly disrupting citrate binding via an unexpected mechanism of inhibition.
PK095

PK095 is a proprietary compound in the guanidine - based F1F0-ATPase inhibitor family.

Sign In Join Free